Sugi Predict

Sugi Predict / Compounds / SCHEMBL703945

SCHEMBL703945

SCHEMBL703945

CCCCCOC(COCC[S])OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 9/20 0.41
▸ LPAR3 Q9UBY5 9/20 0.41
▸ LPAR2 Q9HBW0 6/20 0.41
▸ USP2 O75604 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ DNM1 Q05193 1/20 0.35
▸ LPAR5 Q9H1C0 6/20 0.35
▸ LPAR6 P43657 5/20 0.35
▸ LPAR4 Q99677 5/20 0.35
▸ SPHK1 Q9NYA1 1/20 0.33
▸ TLR2 O60603 2/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ PRKCG P05129 1/20 0.33
▸ PRKCB P05771 1/20 0.33
▸ PRKCA P17252 1/20 0.33
▸ PRKCH P24723 1/20 0.33
▸ PRKCI P41743 1/20 0.33
▸ PRKCE Q02156 1/20 0.33
▸ PRKCQ Q04759 1/20 0.33
▸ PRKCZ Q05513 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28458040 0.87 USP2 (0.48) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL8971436 0.85 USP2 (0.48) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL10908954 0.83 USP2 (0.52) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL9850818 0.83 USP2 (0.52) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL6975117 0.83 USP2 (0.52) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL703310 0.82 LPAR1 (0.41) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL11522848 0.81 HTT (0.53) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL28131148 0.79 TSHR (0.33) LPAR1LPAR3LPAR2USP2DNM1
SCHEMBL6708228 0.79 DNM1 (0.39) LPAR1LPAR3LPAR2USP2HTT
SCHEMBL11513428 0.79 DNM1 (0.39) LPAR1LPAR3LPAR2USP2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11850237-B2 Compounds and methods for treating influenza ROMARK LABORATORIES L.C. (US) 2023-12-26 — — US disclosed
EP-2445349-B1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA ROMARK LABORATORIES LC (US) 2022-02-09 — — EP disclosed
EP-3895706-A1 THIAZOLINIDE COMPOUNDS FOR TREATING NON-INFLUENZA VIRAL INFECTIONS Romark Laboratories, L.C. (US) 2021-10-20 — — EP disclosed
US-20210177809-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA ROMARK LABORATORIES L.C. (US) 2021-06-17 — — US disclosed
US-10912768-B2 Compounds and methods for treating influenza ROMARK LABORATORIES L.C. (US) 2021-02-09 — — US disclosed
US-10577337-B2 Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof ROMARK LABORATORIES, L.C. (US) 2020-03-03 — — US disclosed
US-RE47786-E1 Haloalkyl heteroaryl benzamide compounds ROMARK LABORATORIES L.C. (US) 2019-12-31 — — US disclosed
US-20190307730-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA ROMARK LABORATORIES L.C. (US) 2019-10-10 — — US disclosed
US-20190276417-A1 COMPOSITIONS AND METHODS OF TREATMENT WITH PRODRUGS OF TIZOXANIDE, AN ANALOGUE OR SALT THEREOF ROMARK LABORATORIES, L.C. (US) 2019-09-12 — — US disclosed
US-10363243-B2 Compounds and methods for treating influenza ROMARK LABORATORIES L.C. (US) 2019-07-30 — — US disclosed
WO-2007008529-A2 CELULLAR CHOLESTEROL ABSORPTION MODIFIERS KALYPSYS, INC (US) 2007-01-18 — — WO disclosed
WO-2006124874-A2 INHIBITORS OF B-RAF KINASE KALYPSYS, INC. (US) 2006-11-23 — — WO disclosed
WO-2006124780-A2 IH-BENZO [D] IMIDAZOLE COMPOUNDS AS INHIBITORS OF B-RAF KINASE KALYPSYS, INC. (US) 2006-11-23 — — WO disclosed
US-20060252807-A1 Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders KALYPSYS, INC. 2006-11-09 — — US disclosed
WO-2006116355-A1 ORTHO-TERPHENYL INHIBITORS OF P38 KINASE AND METHODS OF TREATING INFLAMMATORY DISORDERS KALYPSYS, INC. (US) 2006-11-02 — — WO disclosed
US-20060205736-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR KALYPSYS, INC. 2006-09-14 — — US disclosed
US-20060167012-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR KALYPSYS, INC. 2006-07-27 — — US disclosed
WO-2006060424-A2 INDUCIBLE NITRIC OXIDE SYNTHASE DIMERIZATION INHIBITORS KALYPSYS, INC. (US) 2006-06-08 — — WO disclosed
US-20060116515-A1 Inducible nitric oxide synthase dimerization inhibitors KALYPSYS, INC. 2006-06-01 — — US disclosed
WO-2006055187-A1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR KALYPSYS, INC. (US) 2006-05-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116515-A1 Inducible nitric oxide synthase dimerization inhibitors NOS3, NOS2, NOS1 LPAR1 4168/4885LPAR3 3983/4885LPAR2 4116/4885
US-20060167012-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR PPARG, PPARA, PPARD LPAR1 324/4885LPAR3 443/4885LPAR2 308/4885
US-10912768-B2 Compounds and methods for treating influenza HIF1AN, HAVCR2, NEU1 LPAR1 1272/4885LPAR3 1931/4885LPAR2 1972/4885
US-20060252807-A1 Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders MAPK1, MAP3K1, MAPK4 LPAR1 1253/4885LPAR3 1368/4885LPAR2 1177/4885
US-20210177809-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA HIF1AN, HAVCR2, NEU1 LPAR1 1272/4885LPAR3 1931/4885LPAR2 1972/4885
US-20190307730-A1 COMPOUNDS AND METHODS FOR TREATING INFLUENZA HIF1AN, HAVCR2, NEU1 LPAR1 1272/4885LPAR3 1931/4885LPAR2 1972/4885
US-11850237-B2 Compounds and methods for treating influenza HIF1AN, HAVCR2, NEU1 LPAR1 1272/4885LPAR3 1931/4885LPAR2 1972/4885
US-20190276417-A1 COMPOSITIONS AND METHODS OF TREATMENT WITH PRODRUGS OF TIZOXANIDE, AN ANALOGUE OR SALT THEREOF TK1, SLC7A1, SI LPAR1 3851/4885LPAR3 3138/4885LPAR2 4213/4885
US-10577337-B2 Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof TK1, SLC7A1, SI LPAR1 3851/4885LPAR3 3138/4885LPAR2 4213/4885
US-10363243-B2 Compounds and methods for treating influenza HIF1AN, HAVCR2, NEU1 LPAR1 1272/4885LPAR3 1931/4885LPAR2 1972/4885
US-20060205736-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR PPARG, PPARA, PPARD LPAR1 324/4885LPAR3 443/4885LPAR2 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.